Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.38 |
| ▸ | ATXN2 | Q99700 | 4/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31549823 | 0.85 | ENPP2 (0.43) | MGLLENPP2ATXN2IDO1FFAR1 | |
| SCHEMBL20695464 | 0.84 | MGLL (0.47) | MGLLENPP2ATXN2IDO1CYP11B1 | |
| SCHEMBL31549816 | 0.83 | MGLL (0.42) | MGLLENPP2ATXN2IDO1FFAR1 | |
| SCHEMBL31549744 | 0.81 | ENPP2 (0.37) | MGLLENPP2ATXN2SLC6A4 | |
| SCHEMBL19411886 | 0.77 | IDO1 (0.48) | MGLLENPP2ATXN2IDO1FFAR1 | |
| SCHEMBL31549762 | 0.76 | EPHX2 (0.36) | MGLLENPP2ATXN2 | |
| SCHEMBL25324545 | 0.76 | ENPP2 (0.41) | MGLLENPP2ATXN2IDO1LIPG | |
| SCHEMBL30700056 | 0.75 | MGLL (0.41) | MGLLIDO1FFAR1NAAALIPG | |
| SCHEMBL30700026 | 0.75 | MGLL (0.44) | MGLLENPP2ATXN2IDO1NAAA | |
| SCHEMBL30553308 | 0.74 | ENPP2 (0.39) | MGLLENPP2ATXN2IDO1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068347-A1 | NEW HETEROCYCLIC COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2025-04-03 | — | — | WO | claimed |
| WO-2025068347-A1 | NEW HETEROCYCLIC COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2025-04-03 | — | — | WO | disclosed |